{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:10:52Z","timestamp":1790471452434,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2021,3,3]]},"abstract":"<jats:p>\n            Visit-to-visit blood pressure variability (BPV) is associated with cardiovascular events in the general population. Data are scarce in chronic kidney disease. We hypothesized that BPV would be associated with cardiovascular outcomes, death, and end-stage kidney disease (ESKD) and that diuretics would modify these associations in patients with chronic kidney disease. We studied US Veterans with nondialysis chronic kidney disease stages 1\u20135 and hypertension on nondiuretic antihypertensive monotherapy. At the time of second antihypertensive agent prescription, we propensity-matched for exposure to a loop or thiazide diuretic versus any other antihypertensive. BPV was defined as the coefficient of variation of systolic blood pressure over 6 months after second agent prescription. Cox proportional hazards regression measured associations of BPV with a primary cardiovascular event composite (fatal or nonfatal myocardial infarction or ischemic stroke; heart failure hospitalization). Secondary outcomes included all-cause death, each primary outcome component, end-stage kidney disease, and cardiovascular death. There were 31\u2009394 participants in each group. BPV was associated with composite cardiovascular events, hazard ratio (95% CI) at second, third, fourth, and fifth versus first quintile: 1.79 (1.53\u20132.11), 2.32 (1.99\u20132.71), 2.60 (2.24\u20133.02), and 3.12 (2.68\u20133.62). Diuretics attenuated associations between the fourth and fifth BPV quintiles with composite events (\n            <jats:italic>P<\/jats:italic>\n            <jats:sub>interaction<\/jats:sub>\n            =0.03 and 0.04, respectively). BPV was associated with all secondary outcomes except end-stage kidney disease, with no diuretic interactions. BPV was associated with cardiovascular events and death but not end-stage kidney disease in patients with chronic kidney disease, with attenuated associations with cardiovascular events in the diuretic-treated group at high BPV quintiles. Future studies should investigate whether other antihypertensive classes modify these risks.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.16117","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T10:31:43Z","timestamp":1610361103000},"page":"948-959","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1\u20135"],"prefix":"10.1161","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5469-367X","authenticated-orcid":true,"given":"L. Parker","family":"Gregg","sequence":"first","affiliation":[{"name":"From the Division of Nephrology (L.P.G., S.D.N.), Department of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX"},{"name":"Selzman Institute for Kidney Health, Section of Nephrology (L.P.G., S.D.N., W.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX"},{"name":"VA Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, TX (L.P.G., S.S.V.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-4729","authenticated-orcid":true,"given":"S. Susan","family":"Hedayati","sequence":"additional","affiliation":[{"name":"Division of Nephrology (S.S.H., P.N.V.B.), University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, TexasTech University Health Sciences, Dallas (H.Y., C.A.A.)"},{"name":"Pharmacy Service (H.Y., C.A.A.), Medical Service, VA North Texas Health Care System, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Van Buren","sequence":"additional","affiliation":[{"name":"Division of Nephrology (S.S.H., P.N.V.B.), University of Texas Southwestern Medical Center, Dallas"},{"name":"Renal Section (P.N.V.B.), Medical Service, VA North Texas Health Care System, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-7914","authenticated-orcid":true,"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Division of Cardiology (S.B.), University of Texas Southwestern Medical Center, Dallas"},{"name":"Cardiology Section (S.B.), Medical Service, VA North Texas Health Care System, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankar D.","family":"Navaneethan","sequence":"additional","affiliation":[{"name":"From the Division of Nephrology (L.P.G., S.D.N.), Department of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX"},{"name":"Selzman Institute for Kidney Health, Section of Nephrology (L.P.G., S.D.N., W.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9541-6954","authenticated-orcid":true,"given":"Salim S.","family":"Virani","sequence":"additional","affiliation":[{"name":"Division of Cardiology (S.S.V.), Department of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX"},{"name":"Division of Cardiology (S.S.V.), Department of Medicine, Baylor College of Medicine, Houston, TX"},{"name":"VA Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety, Houston, TX (L.P.G., S.S.V.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[{"name":"Selzman Institute for Kidney Health, Section of Nephrology (L.P.G., S.D.N., W.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Population and Data Sciences (C.A.A.), University of Texas Southwestern Medical Center, Dallas"},{"name":"Pharmacy Practice Department, TexasTech University Health Sciences, Dallas (H.Y., C.A.A.)"},{"name":"Pharmacy Service (H.Y., C.A.A.), Medical Service, VA North Texas Health Care System, Dallas, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.12.007"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.054"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12230"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx128"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04030318"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000779"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2014.02.004"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12290"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09788"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4107"},{"key":"e_1_3_5_13_2","first-page":"S1","article-title":"K\/doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney FoundationK\/doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00360119"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwg231"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-014-0527-8"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.49"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12005"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03903"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162255"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2803"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13708"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.0751"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09359"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10131012"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002477"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.06.008"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBP.0000000000000441"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200000004-00003"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2013.1"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.08.004"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0063"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.16117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:37:08Z","timestamp":1715596628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.16117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.16117"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.16117","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"2020-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}